In the interests of transparency, we wish to amend the competing financial interests of this Article to read: “Harvard has filed a provisional patent application. G.M.C. is a founder of Enevolv Inc. and Gen9bio. Other potentially relevant financial interests are listed at http://arep.med.harvard.edu/gmc/tech.html”.
Additional information
The online version of the original article can be found at 10.1038/nature14121
Rights and permissions
About this article
Cite this article
Mandell, D., Lajoie, M., Mee, M. et al. Correction: Corrigendum: Biocontainment of genetically modified organisms by synthetic protein design. Nature 527, 264 (2015). https://doi.org/10.1038/nature15536
Published:
Issue Date:
DOI: https://doi.org/10.1038/nature15536
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
